4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-020871
Chief Commercial Officer sold 17,000 shares at an average $157.01 ($2,669,218)
- Chief Commercial Officer acquired 17,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CRUTCHFIELD BRADFORD · Chief Commercial Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 1 in the form | +17,000 | $1.16 | $19,720 | 51,608 | D |
| 2021-03-12 | Sale : show line 2 in the form | −2,100 | $154.52 | $324,492 | 49,508 | D |
| 2021-03-12 | Sale : show line 3 in the form | −3,807 | $155.54 | $592,148 | 45,701 | D |
| 2021-03-12 | Sale : show line 4 in the form | −3,606 | $156.52 | $564,404 | 42,095 | D |
| 2021-03-12 | Sale : show line 5 in the form | −2,211 | $157.70 | $348,684 | 39,884 | D |
| 2021-03-12 | Sale : show line 6 in the form | −3,176 | $158.85 | $504,513 | 36,708 | D |
| 2021-03-12 | Sale : show line 7 in the form | −2,100 | $159.51 | $334,977 | 34,608 | D |
| Open-market sales · 17,000 sh · avg $157.01 · $2,669,218 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −17,000 | $1.16 | 2027-02-03 | 17,000 | 579,000 | D |
Loading xslF345X03/doc4.xml…